APstem Therapeutics
PrivateLast Round
VC Round
Sep 7, 2023
Total Funding Raised
$4.3M
Company Overview
APstem Therapeutics is a biotechnology company that develops regenerative cell therapies based on its proprietary Guide-Integrated Adult Stem Cells (giaSCs) platform for the treatment of chronic and incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
APstem Therapeutics Comparables
Compare APstem Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cytora Therapeutics | 77% | |
| Seraxis | 67% | |
| Sana Biotechnology | 65% | |
APstem Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Sep 7, 2023 | ||||
| Seed | Sep 1, 2020 | ||||
| Seed | May 1, 2019 | ||||
| Seed | Jan 17, 2018 | ||||
| Accelerator | Jan 1, 2017 |
APstem Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| StartX | Seed, Accelerator |
| InnoSpring | Seed |
| Beyond Ventures | Seed |
| MFund | Seed |
| Oriza Ventures | Seed |
APstem Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about APstem Therapeutics's valuation, stock price, and market status.